Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
Lyric Acquires Concert to Advance Healthcare Decision Intelligence and Expand the Lyric42 Platform
Acquisition Reinforces Lyric’s Commitment to Healthcare Decision Intelligence Across the Healthcare Ecosystem
Lyric, a trusted leader in healthcare decision intelligence for payment accuracy, today announced its acquisition of Concert, a precision health payment accuracy leader with proprietary technology for translating machine-readable policies into real-time decisions.
The acquisition advances Lyric’s mission to build the most innovative and impactful company in healthcare decision intelligence. By combining Concert’s proprietary capabilities with Lyric42, Lyric’s Healthcare Decision Intelligence Platform, the company extends its ability to serve clients at a time when advanced diagnostics such as genetic testing and the rapid development of new therapies are reshaping healthcare.
Health plans face urgent demands to manage rising costs and keep pace with rapidly evolving clinical evidence. To meet these demands, plans require solutions that bring policy, data, and decision-making together in the systems they and their providers already use. The combination of Concert’s policy intelligence with the Lyric42 platform delivers that solution to Lyric’s clients at a critical moment.
“Healthcare decision intelligence will define the next decade of this industry, and Lyric is built to lead it,” said Halsey Wise, Lyric CEO. “Healthcare is entering a new era where frontier capabilities are propelling precision diagnostics, personalized therapies, specialty medicines, novel treatment modalities, and rapidly evolving clinical evidence. These themes will all redefine patient care. By combining Concert’s evidence-based, precision medicine capabilities with Lyric’s AI-powered Healthcare Decision Intelligence Platform, we offer our clients critical insights and intelligence. On behalf of our health plan clients, we continue to innovate and activate Lyric42 to create the most unique and powerful decision intelligence platform in the marketplace.”
Concert brings to Lyric a proprietary approach for building machine-readable clinical policy, developed over more than a decade of work in precision health payment accuracy.
“Concert was built on the conviction that clinical and administrative policy should be transparent, evidence-based, and computable, delivered into the systems that health plans and providers actually use to make decisions,” said Rob Metcalf, CEO at Concert…
Full release here, originally announced July 15th, 2026.
SpinSci Acquires Dialog Health, the Leader in Patient Communications for Health Systems
Acquisition Adds Enterprise-Scale RCS-Powered Patient Texting to SpinSci’s Generative AI-Powered Patient Access Solution
SpinSci, the agentic AI company for patient access, today announced it has acquired Dialog Health, a patient communication platform trusted by Fortune 500 health systems, health plans, and ambulatory surgery centers. The acquisition expands SpinSci’s AI-powered patient access platform by adding Dialog Health’s proven patient engagement and communication capabilities, creating a more connected healthcare experience. Together, the companies will deliver a seamless patient journey—from proactive engagement and access to care through workflow automation and issue resolution—while accelerating innovation through greater scale, resources, and investment.
Dialog Health brings a proven two-way texting and RCS platform with reach rates of up to 96%, helping healthcare organizations engage patients through automated workflows and communications that support appointment reminders, confirmations, recall, orders, surveys, billing follow-up, and staff engagement, all through seamless integrations with leading healthcare EHRs and systems. That capability complements SpinSci’s existing Voice AI-powered patient access and notification solutions, giving health systems a unified platform for proactive patient engagement across both voice and text.
“From the start, Dialog Health has been singularly focused on helping healthcare organizations connect with their patients through two-way texting, real conversational engagement, and doing it better than anyone in the space,” said Andy Asava, CEO at SpinSci. “Their platform is trusted by some of the largest health systems in the country, and the results they have delivered speak for themselves. We are honored to welcome this talented team to SpinSci.”
Both companies share a defining trait: a singular, multi-decade focus on healthcare. Dialog Health built its platform specifically for the realities of healthcare communication, including HIPAA, TCPA, and CTIA compliance, rather than retrofitting a generic marketing texting tool. This common focus between SpinSci and Dialog Health makes the integration far deeper than a typical acquisition.
“We have spent more than a decade proving that the right message, at the right time, drives patient action, improves experiences, and protects revenue,” said Sean Roy, CEO at Dialog Health…
Full release here, originally announced July 14th, 2026.
No comments:
Post a Comment